| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AVROBIO Inc (NASDAQ: AVRO)
AVRO Technical Analysis
5
| As on 9th Jun 2023 AVRO STOCK Price closed @ 1.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.25 & Strong Sell for SHORT-TERM with Stoploss of 2.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AVROSTOCK Price
| Open | 1.18 | Change | Price | % |
| High | 1.26 | 1 Day | 0.02 | 1.67 |
| Low | 1.16 | 1 Week | 0.04 | 3.39 |
| Close | 1.22 | 1 Month | 0.34 | 38.64 |
| Volume | 1236670 | 1 Year | -2.63 | -68.31 |
| 52 Week High 4.04 | 52 Week Low 0.58 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AVRO Daily Charts |
AVRO Intraday Charts |
Whats New @ Bazaartrend |
AVRO Free Analysis |
|
|
AVRO Important Levels Intraday
| RESISTANCE | 1.41 |
| RESISTANCE | 1.35 |
| RESISTANCE | 1.31 |
| RESISTANCE | 1.27 |
| SUPPORT | 1.17 |
| SUPPORT | 1.13 |
| SUPPORT | 1.09 |
| SUPPORT | 1.03 |
AVRO Forecast May 2024
| 4th UP Forecast | 3.2 |
| 3rd UP Forecast | 2.57 |
| 2nd UP Forecast | 2.17 |
| 1st UP Forecast | 1.78 |
| 1st DOWN Forecast | 0.66 |
| 2nd DOWN Forecast | 0.27 |
| 3rd DOWN Forecast | -0.13 |
| 4th DOWN Forecast | -0.76 |
AVRO Weekly Forecast
| 4th UP Forecast | 2.07 |
| 3rd UP Forecast | 1.80 |
| 2nd UP Forecast | 1.63 |
| 1st UP Forecast | 1.46 |
| 1st DOWN Forecast | 0.98 |
| 2nd DOWN Forecast | 0.81 |
| 3rd DOWN Forecast | 0.64 |
| 4th DOWN Forecast | 0.37 |
AVRO Forecast2024
| 4th UP Forecast | 8.14 |
| 3rd UP Forecast | 5.92 |
| 2nd UP Forecast | 4.55 |
| 1st UP Forecast | 3.18 |
| 1st DOWN Forecast | -0.74 |
| 2nd DOWN Forecast | -2.11 |
| 3rd DOWN Forecast | -3.48 |
| 4th DOWN Forecast | -5.7 |
AVROBIO Inc ( NASDAQ USA Symbol : AVRO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AVRO Business Profile
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's lead product candidate is AVR-RD-01, a gene therapy which is in ongoing company-sponsored Phase 2 clinical trial and investigator-sponsored Phase 1 clinical trial for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in Phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, which is in preclinical development to treat Pompe disease; AVR-RD-04 that is in investigator-sponsored Phase 1/2 clinical trial to treat cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage to treat Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: Building 300, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service